Fecal microbiota transplantation in gastrointestinal disorders: time for precision medicine

Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating inflammatory bowel diseases and irritable bowel syndrome in an increasing number of randomized controlled trials. Recently published data gives striking insights into the factors associated with FMT success paving the road...

Descripción completa

Detalles Bibliográficos
Autores principales: Benech, Nicolas, Sokol, Harry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329555/
https://www.ncbi.nlm.nih.gov/pubmed/32605650
http://dx.doi.org/10.1186/s13073-020-00757-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329555/
https://www.ncbi.nlm.nih.gov/pubmed/32605650
http://dx.doi.org/10.1186/s13073-020-00757-y

Ejemplares similares